News

Filter results


 

Pharmacy Times: Chemotherapies May Have Varying Long-Term Cardiovascular Risk

February 6, 2019

By studying the outcomes of more than 28,000 long-term childhood cancer survivors in the United States and Europe, researchers found that exposure to different anthracyclines results in variable long-term cardiovascular risk.


Placeholder photo

Breakthrough in Medical F19 Syrup (Sample)

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris nec massa nunc. Mauris at urna rutrum, venenatis nibh ut, pellentesque metus. Curabitur pellentesque purus est, vulputate suscipit tortor placerat sit amet. Donec non elit sit amet augue i …


Oncology Learning Network: Podcast – Daunorubicin Decreases Long-Term Cardiomyopathy Risk in Cancer Survivors

January 31, 2019

In an interview with Oncology Learning Network, Gregory J. Aune, MD, Assistant Professor of Pediatrics at UT Health San Antonio and Greehey Children’s Cancer Research Institute, discussed his team’s findings from a multicenter study evaluating the long …


Science Daily: Do all chemotherapies have equal long-term heart risk? (Aune & Tomlinson Labs)

January 31, 2019

In long-term survivors of childhood cancer, cardiovascular disease is a leading cause of early death from non-cancer causes. In a new study, published Jan. 31 in JAMA Oncology, researchers compared four chemotherapy drugs with the development of cardio …


Drug Discovery & Development: Do All Chemotherapies Have Equal Long-Term Heart Risk?

January 31, 2019

Gregory Aune, M.D., Ph.D., of UT Health San Antonio, served on a team that found different chemotherapy drugs used to treat children with cancer appear to have different risks long term for cardiomyopathy (abnormal heart muscle with impaired function). …


UT Health SA Newsroom: Do all chemotherapies have equal heart risk long term?

January 31, 2019

Study of 28,000 childhood cancer survivors finds important differences In long-term survivors of childhood cancer, cardiovascular disease is a leading cause of early death from non-cancer causes. In a new study, published Jan. 31 in JAMA Oncology, rese …


EurekAlert: Do all chemotherapies have equal long-term heart risk?

January 21, 2019

SAN ANTONIO — In long-term survivors of childhood cancer, cardiovascular disease is a leading cause of early death from non-cancer causes. In a new study, published Jan. 31 in JAMA Oncology, researchers compared four chemotherapy drugs with the develo …


Tiny molecule has big effect in childhood brain tumor studies

December 6, 2018

Sometimes small things make the biggest difference. A new study by UT Health San Antonio researchers found that a molecule thousands of times smaller than a gene are able to kill medulloblastoma, the most common childhood brain cancer.


Alex’s Lemonade Stand: The Crazy 8 Initiative Topics & Teams

October 1, 2018

ALSF launched the Crazy 8 Initiative to detail roadmaps toward cures for specific, hard-to-treat childhood cancers. This collaborative effort kicked off in the fall of 2018 with a meeting that brought together more than 90 top scientists from around th …


YouTube: Children’s Cause, Challenges in Clinical Trial Design

September 18, 2018

CHILDHOOD CANCER HEARING LOSS AN EXTERNALLY-LED PATIENT-FOCUSED DRUG DEVELOPMENT WORKSHOP: CHEMOTHERAPY-INDUCED HEARING LOSS IN PEDIATRIC ONCOLOGY 3:25-3:35 Challenges in Clinical Trial Design in Chemotherapy-Induced Hearing Loss | Greg Aune, MD, PhD, …